Author:
Kleinert Stefan,Tony Hans-Peter,Krause Andreas,Feuchtenberger Martin,Wassenberg Siegfried,Richter Constanze,Röther Ekkehard,Spieler Wolfgang,Gnann Holger,Wittig Bianca M.
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy,Rheumatology
Reference25 articles.
1. Breedveld FC, Weisman MH, Kavanaugh AF et al. (2006) The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 54(1):26–37. doi: 10.1002/art.21519
2. Burmester GR, Mariette X, Montecucco C et al (2007) Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the research in active rheumatoid arthritis (ReAct) trial. Ann Rheum Dis 66(6):732–739. doi: 10.1136/ard.2006.066761
3. Chen YF, Jobanputra P, Barton P et al (2006) A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. Health Technol Assess 2006 10(42):iii–iv, xi–xiii, 1–229
4. Furst DE, Schiff MH, Fleischmann RM et al (2003) Adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, and concomitant standard anti-rheumatic therapy for the treatment of rheumatoid arthri-tis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). J Rheumatol 30(12):2563–2571
5. Keystone EC, Kavanaugh AF, Sharp JT et al (2004) Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheuma-toid arthritis receiving con-comitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial. Arthritis Rheum 2004; 50(5):1400–1411. doi: 10.1002/art.20217
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献